Alwhaibi A, Alenazi M, Alnofaie S, Aldekhail A, Alanazi R, Alghadeer S
J Clin Med. 2024; 13(16).
PMID: 39201062
PMC: 11355607.
DOI: 10.3390/jcm13164918.
Deng Y, Li H, Park M
Int J Environ Res Public Health. 2022; 19(15).
PMID: 35954856
PMC: 9368303.
DOI: 10.3390/ijerph19159491.
Zhou B, Li Q, Qin L, Li Z, Jin K, Dai J
Transl Lung Cancer Res. 2021; 10(10):3973-3982.
PMID: 34858785
PMC: 8577968.
DOI: 10.21037/tlcr-21-839.
Gao X, Zhang K, Cao S, Hou S, Wang T, Guo W
Cancer Manag Res. 2020; 12:3571-3578.
PMID: 32547194
PMC: 7245442.
DOI: 10.2147/CMAR.S250422.
Faury S, Foucaud J
PLoS One. 2020; 15(1):e0227344.
PMID: 31978145
PMC: 6980610.
DOI: 10.1371/journal.pone.0227344.
Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology.
Warsame R, DSouza A
Mayo Clin Proc. 2019; 94(11):2291-2301.
PMID: 31563425
PMC: 6832764.
DOI: 10.1016/j.mayocp.2019.04.005.
Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis.
Yin X, Yan D, Qiu M, Huang L, Yan S
BMC Cancer. 2019; 19(1):95.
PMID: 30665432
PMC: 6341615.
DOI: 10.1186/s12885-018-5251-3.
Usability testing of EirV3-a computer-based tool for patient-reported outcome measures in cancer.
Krogstad H, Sundt-Hansen S, Hjermstad M, Hagensen L, Kaasa S, Loge J
Support Care Cancer. 2018; 27(5):1835-1844.
PMID: 30173402
DOI: 10.1007/s00520-018-4435-3.
FORECAST - A cloud-based personalized intelligent virtual coaching platform for the well-being of cancer patients.
Kyriazakos S, Valentini V, Cesario A, Zachariae R
Clin Transl Radiat Oncol. 2018; 8:50-59.
PMID: 29594242
PMC: 5862678.
DOI: 10.1016/j.ctro.2017.11.006.
A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer.
Goldkuhle M, Narayan V, Weigl A, Dahm P, Skoetz N
BMJ Open. 2018; 8(3):e020869.
PMID: 29581210
PMC: 5875625.
DOI: 10.1136/bmjopen-2017-020869.
A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve.
Wilson M, Friedlander M, Joly F, Oza A
Oncologist. 2017; 23(2):203-213.
PMID: 29118265
PMC: 5813744.
DOI: 10.1634/theoncologist.2017-0297.
The Humanistic Burden of Small Cell Lung Cancer (SCLC): A Systematic Review of Health-Related Quality of Life (HRQoL) Literature.
Bennett B, Wells J, Panter C, Yuan Y, Penrod J
Front Pharmacol. 2017; 8:339.
PMID: 28663730
PMC: 5471303.
DOI: 10.3389/fphar.2017.00339.
Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer.
Zahra A, Chang T, Hejleh T, Furqan M, Clamon G, Bhatia S
J Oncol Transl Res. 2016; 2(1).
PMID: 27981260
PMC: 5154686.
Evaluation and reporting of quality of life outcomes in phase III chemotherapy trials for poor prognosis malignancies.
Hamaker M, Schulkes K, Ten Bokkel Huinink D, van Munster B, van Huis L, van den Bos F
Qual Life Res. 2016; 26(1):65-71.
PMID: 27381254
DOI: 10.1007/s11136-016-1360-0.
Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials.
Efficace F, Fayers P, Pusic A, Cemal Y, Yanagawa J, Jacobs M
Cancer. 2015; 121(18):3335-42.
PMID: 26079197
PMC: 4755292.
DOI: 10.1002/cncr.29489.
Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer.
Liu C, Yao Y, Wang W
Med Oncol. 2014; 31(10):207.
PMID: 25178940
DOI: 10.1007/s12032-014-0207-1.
